Table 2.

Non-serious treatment-emergent adverse events (TEAE).

Related treatment-emergent adverse events Reported term	Oxaloacetate (N = 42)	Control (N = 40)
Headache	3 (7.1%)	0
Nausea	3 (7.1%)	1 (2.5%)
Diarrhea	1 (2.4%)	1 (2.5%)
Abdominal cramping	2 (4.8%)	0
Abdominal pain	2 (4.8%)	0
Change in bowel habits	1 (2.4%)	1 (2.5%)
Chest pain	0	1 (2.5%)
Migraine	0	1 (2.5%)
Urinary tract infection	0	1 (2.5%)
Anorexia	1 (2.4%)	0
Cervicogenic headache	1 (2.4%)	0
Dry nostril	1 (2.4%)	0
Jackhammer esophagus	0	1 (2.5%)
Hot flashes	1 (2.4%)	0
Intermittent chest pressure	1 (2.4%)	0
Lower abdominal pain	1 (2.4%)	0
Myalgias of rhomboids along the spine	1 (2.4%)	0
Numbness of left leg	0	1 (2.5%)
Numbness of the face	0	1 (2.5%)
Numbness of the left arm	0	1 (2.5%)
Pain in the left side of the jaw	0	1 (2.5%)
Pruritic left arm	0	1 (2.5%)
Sinus infection	0	1 (2.5%)
Sore muscles	1 (2.4%)	0
Stomach upset	1 (2.4%)	0
Thoughts of self-harm	0	1 (2.5%)
Vomit	0	1 (2.5%)
Word finding difficulty	1 (2.4%)	0
Worsening of hypertension	0	1 (2.5%)